MO01.29 Randomized, Open-Label Study of Bintrafusp Alfa vs. Pembrolizumab as First-Line (1L) Treatment in Patients with PD-L1–Expressing Advanced Non-Small Cell Lung Cancer (NSCLC)

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 16; no. 1; pp. S27 - S28
Main Authors Ahn, M.-J., Barlesi, F., Felip, E., Garon, E., Martin, C.M., Vokes, E., Koenig, A., Dussault, I., Ojalvo, L.S., Paz-Ares, L.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.01.2021
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2020.10.134